首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2011年 11期 => 专家论坛 =>“可能切除的”胰腺癌的外科治疗策..
“可能切除的”胰腺癌的外科治疗策略
Surgical therapy strategies of borderline resectable pancreatic cancer
文章发布日期:2011年10月18日  来源:  作者:马永蔌 杨尹默  点击次数:4152次  下载次数:661次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:“可能切除的”胰腺癌介于“可切除”与“不可切除”之间,其定义的主要内涵是肠系膜上静脉、门静脉、肠系膜上动脉或肝总动脉是否为肿瘤侵犯及是否可切除重建,是目前的热点课题。“可能切除的”胰腺癌所涉及的外科相关问题包括:联合血管切除的安全性、有效性;淋巴清扫范围;标本切缘检测的标准化等。治疗方面建议对此类患者行新辅助放化疗,以增加R0切除的几率及可能性,但具体方案尚不统一,亦无RCT研究佐证。在目前多学科治疗模式及理念下,R1切除的价值及意义值得重新审视。
【Abstract】:The “borderline resectable” pancreatic cancer is a distinct subset which blurs the distinction between resectable and locally advanced disease. Patients with borderline resectable pancreatic cancer include those whose tumors have invaded either superior mesenteric vein, portal vein, common hepatic artery or superior mesenteric artery, but are still amenable to resection and reconstruction. The issues of surgical treatment for borderline resectable pancreatic cancer are as follows: the safety and efficacy of vascular resection and reconstruction, the boundary of extended lymphadenectomy, and the standardized examination of resection margin. A preoperative chemotherapy is recommended for these patients to maximize the potential for an R0 resection, despite the fact there is still no standard chemotherapy regimen or RCT research evidences. Under the current concept of multidisciplinary treatment for this disease, the clinical value of an R1 resection for the borderline resectable pancreatic cancer should be reconsidered.
【关键字】:胰腺肿瘤
【Key words】:pancreatic neoplasms
【引证本文】:

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号